Home » Topics » BioWorld

BioWorld
RSS

BIOTECH DEVELOPMENT EXTENDS WARRANTS

Dec. 10, 1991

SPHINX FILES FOR 3 MILLION-SHARE IPO

Dec. 10, 1991

OXANDRIN AVAILABLE AS TREATMENT IND

Dec. 10, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 9, 1991

TESTING APPROVAL BUMPS SYNERGEN STOCK

Dec. 9, 1991

COURT TO RULE ON MOTION TO BLOCK NICODERM

Dec. 9, 1991

BIOTECHNICA UPROOTS BIOTECH BUSINESS

Dec. 9, 1991

GROWING PIPELINE FOR SEPSIS TREATMENTS

Dec. 9, 1991

BUSH CONSIDERS BIOTECH INITIATIVE

Dec. 6, 1991

AMGEN WINS RULING IN EPO DISPUTE

Dec. 6, 1991

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...